February 15, 2022 11:27 AM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Su­per Bowl scores last minute ad from di­ag­nos­tic; BBC spot­lights As­traZeneca vac­cine

Beth Snyder Bulik

Senior Editor

Su­per Bowl ads aren’t typ­i­cal­ly a last-minute buy. Get­ting a spot be­fore in­ven­to­ry sells out is usu­al­ly an is­sue, but so is tak­ing the time to cre­ate a world-is-watch­ing TV spot. Di­ag­nos­tics tech com­pa­ny Cue Health, how­ev­er, whipped up its Su­per Bowl ad idea and com­mer­cial in less than a month.

The smart, at-home Covid-19 health test­ing de­vice mak­er worked with its ad agency Don­er to cre­ate and shoot two dif­fer­ent ads, choos­ing its game win­ner just eight days ago, ac­cord­ing to Ad­ver­tis­ing Age.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J’s chal­lenge to As­traZeneca in lung can­cer takes flight with PhI­II PFS win

Fed­er­al gov­ern­ment shut­down watch: FDA and in­dus­try prep for like­ly clo­sure Oct. 1

FDA ap­proves ma­jor de­pres­sive drug af­ter re­ject­ing it mul­ti­ple times in past two decades

Stephen Hahn’s liq­uid biop­sy com­pa­ny Har­bin­ger Health rais­es $140M Se­ries B to launch first can­cer tests by 2025

How aca­d­e­m­ic cen­ters are try­ing to keep their promis­ing drug dis­cov­er­ies out of the ‘val­ley of death’

sponsored

Da­ta Qual­i­ty 2.0: The Fu­ture of Re­al-World Ev­i­dence

A service from the Financial Times